Studies on articular and general toxicity of orally administered ozenoxacin in juvenile rats and dogs

Systemic bioavailability and safety of twice-daily topical ozenoxacin 1% cream in adults and children with impetigo

(2014) Savion Gropper et al.   Future Microbiology

Skin tissue exposure of once- versus twice-daily topical ozenoxacin 2% cream: a Phase I study in healthy volunteers

(2014) Savion Gropper et al.   Future Microbiology

Ozenoxacin 1% cream in the treatment of impetigo: a multicenter, randomized, placebo- and retapamulin-controlled clinical trial

(2014) Savion Gropper et al.   Future Microbiology

In VitroActivity of Ozenoxacin against Quinolone-Susceptible and Quinolone-Resistant Gram-Positive Bacteria

(2013) Y. López et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Chondrotoxicity and toxicokinetics of novel quinolone antibacterial agents DC-159a and DX-619 in juvenile rats

(2010) Koichi Goto et al.   TOXICOLOGY

Gene expression profiles in the articular cartilage of juvenile rats receiving the quinolone antibacterial agent ofloxacin

(2008) Koichi Goto et al.   TOXICOLOGY